BS
BMY icon

Boenning & Scattergood’s Bristol-Myers Squibb BMY Stock Holding History

Boenning & Scattergood’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.47M Sell
47,463
-770
-2% -$58.1K 0.56% 42
2022
Q3 		$3.43M Buy
48,233
+742
+2% +$53.8K 0.7% 35
2022
Q2 		$3.66M Buy
47,491
+28
+0.1% +$2.13K 0.69% 35
2022
Q1 		$3.47M Sell
47,463
-993
-2% -$66.7K 0.56% 42
2021
Q4 		$3.02M Sell
48,456
-6,797
-12% -$399K 0.48% 51
2021
Q3 		$3.27M Buy
55,253
+3,721
+7% +$245K 0.57% 42
2021
Q2 		$3.44M Sell
51,532
-4,829
-9% -$315K 0.6% 40
2021
Q1 		$3.56M Sell
56,361
-5,138
-8% -$320K 0.68% 36
2020
Q4 		$3.81M Buy
61,499
+3,350
+6% +$206K 0.81% 24
2020
Q3 		$3.51M Buy
58,149
+11,328
+24% +$682K 0.84% 25
2020
Q2 		$2.75M Buy
46,821
+615
+1% +$36.8K 0.74% 29
2020
Q1 		$2.58M Sell
46,206
-386
-0.8% -$23.6K 0.89% 25
2019
Q4 		$2.99M Buy
46,592
+5,102
+12% +$292K 0.77% 32
2019
Q3 		$2.1M Sell
41,490
-4,935
-11% -$232K 0.61% 43
2019
Q2 		$2.1M Sell
46,425
-531
-1% -$24.7K 0.62% 40
2019
Q1 		$2.24M Buy
46,956
+2
+0% +$100 0.67% 37
2018
Q4 		$2.44M Sell
46,954
-2,484
-5% -$133K 0.85% 25
2018
Q3 		$3.07M Sell
49,438
-2,471
-5% -$147K 0.98% 23
2018
Q2 		$2.87M Buy
+51,909
New +$2.8M 0.94% 22

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Boenning & Scattergood's BMY Position: Q4 2022 in Review

Boenning & Scattergood reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q4 2022, selling an estimated $58.1K and leaving 47,463 shares worth $3.47M. The position accounts for 0.56% of the portfolio, ranked #42.

Boenning & Scattergood first reported a position in BMY in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.81M in Q4 2020. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Boenning & Scattergood held 47,463 shares of Bristol-Myers Squibb worth $3.47M as of Q4 2022.
  • Boenning & Scattergood sold 770 Bristol-Myers Squibb shares in Q4 2022, an estimated $58.1K.
  • Bristol-Myers Squibb made up 0.56% of Boenning & Scattergood's portfolio in Q4 2022, its #42 holding.
  • Boenning & Scattergood first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Bristol-Myers Squibb position peaked at $3.81M in Q4 2020.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.